Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Karyopharm Therapeutics Inc. - Common Stock
(NQ:
KPTI
)
8.160
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 22, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,132
Open
8.160
Bid (Size)
8.300 (3,800)
Ask (Size)
9.470 (100)
Prev. Close
8.160
Today's Range
8.160 - 8.160
52wk Range
3.650 - 10.99
Shares Outstanding
114,010,448
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Karyopharm Therapeutics Teases ASCO SENTRY Data as FDA Path Comes Into Focus
↗
Today 7:06 EDT
Karyopharm Therapeutics (NASDAQ:KPTI) executives said the company expects to provide a fuller presentation of its Phase 3 SENTRY trial data for selinexor in myelofibrosis at the upcoming ASCO...
Via
MarketBeat
Karyopharm (KPTI) Q1 2026 Earnings Transcript
↗
May 14, 2026
Karyopharm (KPTI) Q1 2026 Earnings Transcript
Via
The Motley Fool
Performance
YTD
+13.5%
+13.5%
1 Month
-5.8%
-5.8%
3 Month
-18.6%
-18.6%
6 Month
+46.8%
+46.8%
1 Year
+79.3%
+79.3%
More News
Read More
Karyopharm Therapeutics Q1 Earnings Call Highlights
↗
May 14, 2026
Via
MarketBeat
Topics
Earnings
Karyopharm Therapeutics Inc (NASDAQ:KPTI) Posts Q1 Beat and Highlights ASCO Presentation, Shares Surge 7%
↗
May 14, 2026
Via
Chartmill
Karyopharm Therapeutics Inc (NASDAQ:KPTI) Reports Q4 Revenue Miss and Wider Loss, Stock Falls in Pre-Market
↗
February 12, 2026
Via
Chartmill
Earnings Scheduled For November 3, 2025
↗
November 03, 2025
Via
Benzinga
Karyopharm Therapeutics Earnings Preview
↗
October 31, 2025
Via
Benzinga
Karyopharm (KPTI) Q2 2025 Earnings Transcript
↗
May 04, 2026
Via
The Motley Fool
Karyopharm (KPTI) Q1 2025 Earnings Transcript
↗
May 04, 2026
Via
The Motley Fool
Registration Momentum Builds Across the Oncology Pipeline
February 17, 2026
From
USA News Group
Via
GlobeNewswire
Earnings Outlook For Karyopharm Therapeutics
↗
August 08, 2025
Via
Benzinga
Karyopharm (KPTI) Q4 2025 Earnings Call Transcript
↗
February 12, 2026
Via
The Motley Fool
Topics
Derivatives
Earnings
Karyopharm Therapeutics Inc (NASDAQ:KPTI) Reports Q3 2025 Revenue Beat and Earnings Miss
↗
November 03, 2025
Via
Chartmill
Topics
Earnings
This Palo Alto Networks Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
↗
October 13, 2025
Via
Benzinga
Karyopharm Strengthens Balance Sheet With $100 Million Financing To Extend Cash Runway Into 2026
↗
October 08, 2025
Via
Benzinga
These stocks that are showing activity before the opening bell on Wednesday.
↗
October 08, 2025
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 08, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
September 24, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
September 23, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
September 08, 2025
Via
Benzinga
Top movers analysis in the middle of the day on 2025-08-15: top gainers and losers in today's session.
↗
August 15, 2025
Via
Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
↗
July 11, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
July 11, 2025
Via
Benzinga
Earnings Scheduled For August 11, 2025
↗
August 11, 2025
Via
Benzinga
These Analysts Revise Their Forecasts On Karyopharm Therapeutics After Q1 Results
↗
May 13, 2025
Via
Benzinga
Frequently Asked Questions
Is Karyopharm Therapeutics Inc. - Common Stock publicly traded?
Yes, Karyopharm Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Karyopharm Therapeutics Inc. - Common Stock trade on?
Karyopharm Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Karyopharm Therapeutics Inc. - Common Stock?
The ticker symbol for Karyopharm Therapeutics Inc. - Common Stock is KPTI on the Nasdaq Stock Market
What is the current price of Karyopharm Therapeutics Inc. - Common Stock?
The current price of Karyopharm Therapeutics Inc. - Common Stock is 8.160
When was Karyopharm Therapeutics Inc. - Common Stock last traded?
The last trade of Karyopharm Therapeutics Inc. - Common Stock was at 05/22/26 04:00 PM ET
What is the market capitalization of Karyopharm Therapeutics Inc. - Common Stock?
The market capitalization of Karyopharm Therapeutics Inc. - Common Stock is 930.33M
How many shares of Karyopharm Therapeutics Inc. - Common Stock are outstanding?
Karyopharm Therapeutics Inc. - Common Stock has 930M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today